The dental membrane and bone graft substitute market is estimated to achieve revenue of USD 1.565 billion by the end of 2033 growing at a CAGR of ~9% by 2033. NEW YORK, UNITED STATES, December 22, 2022 /EINPresswire.com/ — Global Dental Membrane and Bone Graft Substitutes Key Market Insights During the forecast period of 2023~2033, … Read more
In our bones, specialized cells called osteoblasts are responsible for building bone substance. A team of researchers led by scientists from the DKFZ-Hector Cancer Institute at the University Medical Center Mannheim and the Hamburg Eppendorf University Medical Center have now identified an enzyme that controls the activity of osteoblasts. An agent that inhibits the activity … Read more
Doctors have long treated cardiovascular disease by focusing on controlling diabetes and blood pressure, lowering cholesterol with drugs like aspirin and statins. Despite these measures, heart disease remains the leading cause of death in the United States, and many patients suffer heart attacks even after controlling for their risk factors, says Salim Hayek, MD, a … Read more
A patient with relapsed T-cell leukemia was administered base-edited T cells in a world-first use of a base-edited cell therapy, in a ‘bench-to-bed’ collaboration between UCL and Great Ormond Street Hospital for Children (OMG). The patient, Alyssa, 13, from Leicester, was diagnosed with T-cell acute lymphoblastic leukemia (T-ALL) in 2021. She received all current conventional … Read more
A one-of-a-kind drug known as modakafusp alfa has shown early potential to fight multiple myeloma, a form of bone marrow cancer, in a study presented by researchers at the University of Pennsylvania Abramson Cancer Center at the American Society for 2022 Hematology. (ASH) Annual Meeting (Abstract 565). Of patients in the multicenter Phase I/II trial … Read more
A one-of-a-kind drug known as modakafusp alfa has shown early potential to fight multiple myeloma, a form of bone marrow cancer, in a study presented by researchers at the University of Pennsylvania Abramson Cancer Center at the American Society for 2022 Hematology. (ASH) Annual Meeting (Abstract 565). Of patients in the multicenter Phase I/II trial … Read more
The building blocks of a structure consist of load-bearing elements that rarely change despite renovations or repairs. They remain intact and consistent over time, but in the human body, our building blocks do the exact opposite. Bones are dynamic: they are constantly breaking down and rebuilding themselves to become stronger versions of themselves. A mutation … Read more
A new device for diagnosing bone fragility invented by the University Hospitals of Geneva (HUG) and the University of Geneva (UNIGE) has been approved for marketing in the European Economic Area and Switzerland. Licensed by the Northern Irish company ProAxsis, it was released this summer. The device is based on a new approach to assess … Read more
OF THE UNION OF NORTH AMERICA, 300 W 57TH STREET, 15TH FLOOR, NEW YORK, NY 10019 CUSTOMER SERVICE: (800) 708-7311 EXT. 236 TO YOUR GOOD HEALTH #12345_20221208 FOR PUBLICATION THE WEEK OF DEC. 5, 2022 (COL. 4) BYLINE: By Keith Roach, MD TITLE: Previous restriction on donating blood is lifted — DEAR DOCTOR. COCKROACH: he … Read more
Two studies comparing injections commonly used to relieve knee osteoarthritis pain found that corticosteroid injections were associated with disease progression. The results of both studies were presented today at the annual meeting of the Radiological Society of North America (RSNA). Osteoarthritis is the most common form of arthritis, affecting 32.5 million adults in the US … Read more